RXSIGHT, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.56 USD | -1.47% |
|
-1.70% | +47.72% |
Presenter SpeechRobert Marcus (Analysts)Good morning. Happy to kick off Day 4 of the JPMorgan ...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Companyâs RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patientâs vision outcomes.
Calendar
2024-06-06
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
59.52
USD
Average target price
72.75
USD
Spread / Average Target
+22.23%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +47.72% | 2.32B | |
| -7.57% | 177B | |
| -2.16% | 106B | |
| -6.99% | 65.54B | |
| -4.65% | 47.09B | |
| +7.38% | 43.43B | |
| +8.14% | 41.77B | |
| +14.07% | 29.55B | |
| +15.53% | 24.83B | |
| -5.97% | 23.54B |
- Stock Market
- Equities
- RXST Stock
- News RxSight, Inc.
- Transcript : RxSight, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-13-2022 09
